Tetrandrine suppresses activation of human subconjunctival fibroblasts in vitro

Current Eye Research

Volumn 33, Issue 7, 2008, Pages 559-565

  Kitano, Ai ^a   Yamanaka, Osamu ^a   Ikeda, Kazuo ^b   Ishida Nishikawa, Iku ^a   Okada, Yuka ^a   Shirai, Kumi ^a   Saika, Shizuya ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibrosis; Myofibroblast; Subconjunctival fibroblast; Tetrandrine; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; SMAD2 PROTEIN; SMAD7 PROTEIN; TETRANDRINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONJUNCTIVA; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; CULTURE MEDIUM; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONOLAYER CULTURE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRABECULECTOMY; UPREGULATION; WESTERN BLOTTING;

ACTINS; BENZYLISOQUINOLINES; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; CONJUNCTIVA; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 46749137187     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802220817     Document Type: Article

References (35)

1. Cordeiro MF, Reichel MB, Gay JA, et al. Transforming growth factor-β1, -β2, and -β3 in vivo: Effects on normal and mitomycin C-modulated conjunctival scarring. Invest Ophthalmol Vis Sci. 1999;40:1975-1982.
2. Saika S, Yamanaka O, Baba Y, et al. Accumulation of latent transforming growth factor-beta binding protein-1 and TGFβ1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol. 2001;239:234-241.
3. Cordeiro MF, Bhattacharya SS, Schultz GS, et al. TGF-β1, -β2, and -β3 in vitro: Biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci. 2000;41:756-763.
4. Daniels JT, Schultz GS, Blalock TD, et al. Mediation of transforming growth factor-β1 stimulated matrix contraction by fibroblasts. Am J Pathol. 2003;163:2043-2052.
5. Cordeiro MF, Mead A, Ali RR, et al. Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003;10:59-71.
6. Elder MJ, Dart JKG, Lightman S. Conjunctival fibrosis in ocular cicatricial pemphigoidthe role of cytokines. Exp Eye Res. 1997;65:165-176.
7. Jampel HD, Roche N, Stark WJ, et al. Transforming growth factor-β in human aqueous humor. Curr Eye Res. 1990;9:963-969.
8. Khaw PT, Chang L, Wong TT, et al. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001;12:143-148.
9. Siriwardena D, Khaw PT, King AJ, et al. Human antitransforming growth factor β2 monoclonal antibody - a new modulator of wound healing in trabeculectomy: A randomized placebo controlled clinical study. Ophthalmology. 2002;109:427-431.
10. Nakamura H, Siddiqui SS, Shen X, et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol Vis. 2004;10:703-711.
11. Lai JH. Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol Sin. 2002;23:1093-1101.
12. Xie QM, Tang HF, Chen JQ, et al. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin. 2002;23:1107-1113.
13. Wang G, Lemos JR, Iadecola C. Herbal alkaloid tetrandrine: From an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci. 2004;25:120-123.
14. Reist RH, Dey RD, Durham JP, et al. Inhibition of proliferative activity of pulmonary fibroblasts by tetrandrine. Toxicol Appl Pharmacol. 1993;122:70-76.
15. Lee SH, Nan JX, Sohn DH. Tetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis. Pharmacol Toxicol. 2001;89:214-216.
16. Park PH, Nan JX, Park EJ, et al. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol Toxicol. 2000;87:261-268.
17. Zhao YZ, Kim JY, Park EJ, et al. Tetrandrine induces apoptosis in hepatic stellate cells. Phytother Res. 2004;18:306-309.
18. Fang LH, Zhang YH, Ma JJ, et al. Inhibitory effects of tetrandrine on the serum- and platelet-derived growth factor-BB-induced proliferation of rat aortic smooth muscle cells through inhibition of cell cycle progression, DNA synthesis, ERK1/2 activation and c-fos expression. Atherosclerosis. 2004;174:215-223.
19. Saika S, Ooshima A, Yamanaka O, et al. Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro. Graefes Arch Clin Exp Ophthalmol. 1996;234:S214-222.
20. Yamanaka O, Saika S, Okada Y, et al. Effects of interferon-gamma on human subconjunctival fibroblasts in the presence of TGFβ1: Reversal of TGFβ-stimulated collagen production. Graefes Arch Clin Exp Ophthalmol. 2003;241:116-124.
21. Saika S, Miyamoto T, Yamanaka O, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-κB, in treatment of corneal alkali burns in mice. Am J Pathol. 2005;166:1393-1403.
22. Saika S, Ikeda K, Yamanaka O, et al. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol. 2005;166:1405-1418.
23. Saika S, Ikeda K, Yamanaka O, et al. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest. 2004;84:1259-1270.
24. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol. 2004;164:651-663.
25. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13:7-12, review.
26. Ishida I, Saika S, Ohnishi Y. Effect of minoxidil on rabbit lens epithelial cell behavior in vitro and in situ. Graefes Arch Clin Exp Ophthalmol. 2001;239:770-777.
27. Saika S, Ooshima A, Hashizume N, et al. Effect of lysyl hydroxylase inhibitor, minoxidil, on ultrastructure and behavior of cultured rabbit subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol. 1995;233:347-353.
28. Hamid R, Rotshteyn Y, Rabadi L, et al. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro. 2004;18:703-710.
29. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J. 2004;18:816-827.
30. Roberts AB, Piek E, Bottinger EP, et al. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest. 2001:720(Suppl):43S-47S.
31. Connor Jr TB, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
32. Picht G, Welge-Luessen U, Grehn F, et al. Transforming growth factor β2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001;239:199-207.
33. Evans RA, Tian YC, Steadman R, et al. TGF-β1-mediated fibroblast-myofibroblast terminal differentiationthe role of Smad proteins. Exp Cell Res. 2003;282:90-100.
34. Kitano A, Saika S, Yamanaka O, et al. Genipin suppresses subconjunctival fibroblast migration, proliferation and myofibroblast transdifferentiation. Ophthalmic Res. 2006;38:355-360.
35. Kitano A, Saika S, Yamanaka O, et al. Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci. 2007;48:5013-5022.